Bristol-Myers Squibb Co (BMY)
44.70
-4.16
(-8.51%)
USD |
NYSE |
Apr 25, 16:00
44.95
+0.25
(+0.56%)
After-Hours: 20:00
Bristol-Myers Squibb Total Long Term Debt (Quarterly): 39.77B for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 39.77B |
September 30, 2023 | 37.60B |
June 30, 2023 | 37.68B |
March 31, 2023 | 37.83B |
December 31, 2022 | 39.32B |
September 30, 2022 | 39.10B |
June 30, 2022 | 42.06B |
March 31, 2022 | 44.97B |
December 31, 2021 | 44.55B |
September 30, 2021 | 44.74B |
June 30, 2021 | 45.16B |
March 31, 2021 | 46.28B |
December 31, 2020 | 50.68B |
September 30, 2020 | 44.95B |
June 30, 2020 | 46.67B |
March 31, 2020 | 46.71B |
December 31, 2019 | 46.73B |
September 30, 2019 | 24.96B |
June 30, 2019 | 24.98B |
March 31, 2019 | 6.016B |
December 31, 2018 | 7.349B |
September 30, 2018 | 7.307B |
June 30, 2018 | 7.387B |
March 31, 2018 | 7.70B |
December 31, 2017 | 7.962B |
Date | Value |
---|---|
September 30, 2017 | 8.443B |
June 30, 2017 | 8.217B |
March 31, 2017 | 8.434B |
December 31, 2016 | 6.708B |
September 30, 2016 | 6.826B |
June 30, 2016 | 6.736B |
March 31, 2016 | 6.699B |
December 31, 2015 | 6.689B |
September 30, 2015 | 7.274B |
June 30, 2015 | 7.37B |
March 31, 2015 | 7.457B |
December 31, 2014 | 7.832B |
September 30, 2014 | 7.668B |
June 30, 2014 | 7.737B |
March 31, 2014 | 7.648B |
December 31, 2013 | 8.34B |
September 30, 2013 | 7.212B |
June 30, 2013 | 7.206B |
March 31, 2013 | 7.894B |
December 31, 2012 | 7.394B |
September 30, 2012 | 7.359B |
June 30, 2012 | 5.445B |
March 31, 2012 | 5.415B |
December 31, 2011 | 5.491B |
September 30, 2011 | 5.619B |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
24.96B
Minimum
Sep 2019
50.68B
Maximum
Dec 2020
41.30B
Average
44.55B
Median
Dec 2021
Total Long Term Debt (Quarterly) Benchmarks
Amgen Inc | 64.61B |
Gilead Sciences Inc | 24.99B |
Johnson & Johnson | 0.00 |
Karuna Therapeutics Inc (DELISTED) | -- |
2seventy bio Inc | 0.00 |